Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06515977

Texture and Colour Enhancement Imaging in Improving Detection and Miss Rate of Premalignant Lesions

Impact of Texture and Color Enhancement Imaging on Detection and Miss Rate of Premalignant Lesions: A Multicentre, Randomized, Tandem Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,964 (estimated)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
45 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized, tandem trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of diagnosis of premalignant lesions.

Conditions

Interventions

TypeNameDescription
PROCEDURETXI (Group A)Patients in Group A will undergo colonoscopy with TXI.
PROCEDURETXI followed by WLI (Group B)Patients in group B will first undergo colonoscopy with TXI and every polyp found should be removed. Then switch to WLI for a second withdrawal to detect lesions that were not observed the first time.
PROCEDUREWLI (Group C)Patients in Group C will undergo colonoscopy with WLI.
PROCEDUREWLI followed by TXI (Group D)Patients in group D will first undergo colonoscopy with WLI and every polyp found should be removed. Then switch to TXI for a second withdrawal to detect lesions that were not observed the first time.

Timeline

Start date
2024-08-01
Primary completion
2025-08-01
Completion
2025-08-01
First posted
2024-07-23
Last updated
2024-07-23

Source: ClinicalTrials.gov record NCT06515977. Inclusion in this directory is not an endorsement.